Skip to main content
. 2019 May 2;8(6):2942–2949. doi: 10.1002/cam4.2201

Figure 4.

Figure 4

Overall survival of patients with chronic myeloid leukemia in A, the chronic phase; B, the blastic phase; and C, the accelerated phase treated at the National Cancer Institute – Mexico, 2000‐2016, according to hematologic response. P‐values were obtained using the log‐rank test